Yuanbao Inc.
YBTechnologyNASDAQSoftware - Application
Scan Results
Daily timeframePart of the technology sector, Yuanbao Inc. (YB) is listed under Software - Application. At a $632.2M market cap, Yuanbao Inc. ranks as a small-cap company within technology. The company offers medical, critical illness, accident, property, and pet insurance products.
Market Cap
$632.2M
Beta
—
P/E (TTM)
3.24
P/E (Fwd)
2.75
EPS (TTM)
$4.23
EPS (Fwd)
$4.98
ROE
47.9%
ROA
21.3%
Cash
$4.67B
Total Debt
$4.3M
Free CF
—
52W Change
-41.8%
Annual Financials
Cash vs Debt
Where YB stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, YB finished 10.57% below its 150-day moving average ($15.33) and 15.47% below its 200-day moving average ($16.22). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is YB overbought or oversold?
At the September 3, 2026 close, YB's RSI(14) was 52.3, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $4.67B in cash and $4.3M in debt, YB maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Return on equity stands at 47.9%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 21.3% further supports the picture of efficient asset utilization. Revenue has grown from $850.2M (2022) to $4.37B (2025), reflecting a 414% increase over the period.
With cash comfortably exceeding debt, YB has financial flexibility that may help navigate uncertain periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Yuanbao Inc.'s trajectory.